• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

senthil.lingaretnam@unimelb.edu.au

Credentials


Position
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology

Mr Senthil Lingaratnam

Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology

41 Scholarly works
1 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial
    DOI: 10.1093/cid/ciaf409
  • 2025

    Journal article

    An Australasian survey of clinical practices in management of neutropenic fever in adult cancer patients 2023
    DOI: 10.1111/imj.70273
  • 2025

    Journal article

    Usability testing of an online, evidence-based pharmacogenomics education program for pharmacists working in cancer care
    DOI: 10.1016/j.cptl.2025.102478
  • 2025

    Journal article

    Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia
    DOI: 10.1007/s40261-025-01489-w
  • 2025

    Research grants (ARC, NHMRC, MRFF)

    Trial Implementation of Pharmacogenomics to Improve Complex Hospital Care
  • 2025

    Journal article

    Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers
    DOI: 10.1111/cts.70144
  • 2024

    Journal article

    Pharmacogenetic-guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC-PGx): A multicenter clinical trial
    DOI: 10.1111/cts.70083
Senthil Lingaratnam

RECENT SCHOLARLY WORKS

  • 2024

    Journal article

    Utility of 30-Day Mortality Following Systemic Anti-Cancer Treatment as a Quality Indicator in Advanced Lung Cancer
    DOI: 10.1016/j.cllc.2024.04.001
  • 2024

    Journal article

    Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis
    DOI: 10.1177/10781552231180875
  • 2024

    Journal article

    A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer
    DOI: 10.1111/cts.13781
  • 2024

    Journal article

    Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year review
    DOI: 10.1080/20523211.2024.2389120

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224